Daphne Continu 2 mg - 0.035 mg tabl.

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingrédients actifs:

Cyproterone acetate 2 mg (yellow tablet); Ethinylestradiol 35 µg (yellow tablet); Placebo (white tablet)

Disponible depuis:

Ceres Pharma SA-NV

Code ATC:

G03HB01

DCI (Dénomination commune internationale):

Cyproterone acetate; Ethinylestradiol; Placebo

Dosage:

2 mg - 0,035 mg

forme pharmaceutique:

Tablet

Composition:

Cyproterone acetate 2 mg; Ethinylestradiol 35 µg; Placebo

Mode d'administration:

Oral use

Domaine thérapeutique:

Cyproterone and Estrogen

Descriptif du produit:

CTI code: 459191-03 - Pack size: 6 x 28 (21 + 7) - Commercialisation status: NO - FMD code: 05430000476157 - CNK code: 3189677 - Delivery mode: Medical prescription; CTI code: 459191-02 - Pack size: 3 x 28 (21 + 7) - Commercialisation status: NO - FMD code: 05430000476140 - CNK code: 3189701 - Delivery mode: Medical prescription; CTI code: 459191-01 - Pack size: 28 (21 + 7) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 459191-04 - Pack size: 13 x 28 (21 + 7) - Commercialisation status: NO - FMD code: 05430000476164 - CNK code: 3189685 - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: No

Date de l'autorisation:

2014-06-03